计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| M646396-5mg |
5mg |
期货 ![]() |
| |
| M646396-10mg |
10mg |
期货 ![]() |
| |
| M646396-25mg |
25mg |
期货 ![]() |
| |
| M646396-50mg |
50mg |
期货 ![]() |
|
| 规格或纯度 | ≥99% |
|---|---|
| 英文名称 | MRT199665 |
| 生化机理 | MRT199665 是一种强效的 ATP 竞争性、选择性 MARK / SIK / AMPK 抑制剂,对 MARK1/MARK2/MARK3/MARK14 、AMPKα1/AMPKα2 和 SIK1/SIK2/SIK3 的 IC 50 s 分别为 2/2/3/2、10/10 nM 和 110/12/43 nM。MRT199665 在 ME 中导致细胞凋亡 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 产品介绍 |
MRT199665 is a potent and ATP-competitive, selective MARK / SIK / AMPK inhibitor with IC 50 s of 2/2/3/2 nM, 10/10 nM, and 110/12/43 nM for MARK1/MARK2/MARK3/MARK14 , AMPKα1/AMPKα2 , and SIK1/SIK2/SIK3 , respectively MRT199665 causes apoptosis in MEF2C-activated human acute myeloid leukemias (AML) cells MRT199665 inhibits the phosphorylation of SIK substrate CRTC3 at S370 In Vitro MRT199665 (1 μM; pre-treated for 1 h) increases LPS (100 ng/mL; stimulated for up to 24 h)-stimulated IL-10 mRNA and Nurr77 mRNA production, and IL-10 secretion. MRT199665 (1 nM-100 μM; 48 hours) reduces leukemia growth. MRT199665 treatment can block MEF2C S222 phosphorylation in acute myeloid leukemias (AML) cells.\nMRT199665 (10 nM-1000 nM; 12 hours) leads to a dose-dependent reduction in total and pS222 MEF2C. MRT199665 also causes a decrease of total MEF2C protein. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: OCI-AML2 and MOLM-13 cells Concentration: 10, 100, 500, and 1000 nM Incubation Time: 12 hours Result: Led to a dose-dependent reduction in total and pS222 MEF2C, causing more than 40% reduction in MEF2C phosphorylation at 10 nM as compared to untreated cells. Cell Proliferation AssayCell Line: Human AML cell lines OCI-AML2, MV4-11, MOLM-13 and Kasumi-1 with endogenous MEF2C phosphorylation; human AML cell lines NB-4, HEL, HL-60 and U937 lacking MEF2C Concentration: 1 nM, 10 nM, 100n M, 1 μM, 10 μM, 100μM Incubation Time: 48 hours Result: Human AML cell lines with endogenous MEF2C phosphorylation (OCI-AML2, MV4–11, MOLM-13 and Kasumi-1) were more sensitive as compared to cell lines lacking MEF2C (NB-4, HEL, HL-60 and U937), with mean IC 50 of 26±13 versus 990±29 nM, respectively. Form:Solid IC50& Target:MARK1 2 nM (IC 50 ) MARK2 2 nM (IC 50 ) MARK3 3 nM (IC 50 ) MARK4 2 nM (IC 50 ) SIK1 110 nM (IC 50 ) SIK2 12 nM (IC 50 ) SIK3 43 nM (IC 50 ) NUAK1 3 nM (IC 50 ) NUAK2 120 nM (IC 50 ) AMPKα1 10 nM (IC 50 ) AMPKα2 10 nM (IC 50 ) MELK 29 nM (IC 50 ) TBK1 5400 nM (IC 50 ) IKKε 7700 nM (IC 50 ) BRSK2 10000 nM (IC 50 ) |
| 纯度 | ≥99% |
| IIUPAC Name | 7-[(1S)-4-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,5-dimethyl-2-[3-(pyrrolidin-1-ylmethyl)anilino]pyrrolo[2,3-d]pyrimidin-6-one |
|---|---|
| INCHI | 1S/C28H31N5O2/c1-28(2)22-16-29-27(30-19-8-5-7-18(15-19)17-32-13-3-4-14-32)31-25(22)33(26(28)35)23-12-11-21-20(23)9-6-10-24(21)34/h5-10,15-16,23,34H,3-4,11-14,17H2,1-2H3,(H,29,30,31)/t23-/m0/s1 |
| InChi Key | OFIFLUFVENTCNZ-QHCPKHFHSA-N |
| Smiles | CC1(C2=CN=C(N=C2N(C1=O)C3CCC4=C3C=CC=C4O)NC5=CC=CC(=C5)CN6CCCC6)C |
| Isomeric SMILES | CC1(C2=CN=C(N=C2N(C1=O)[C@H]3CCC4=C3C=CC=C4O)NC5=CC=CC(=C5)CN6CCCC6)C |
| PubChem CID | 71725150 |
| MeSH Entry Terms | MRT199665 |
| 分子量 | 469.58 |
| 溶解性 | DMSO : 125 mg/mL (266.20 mM; Need ultrasonic) |
|---|---|
| 分子量 | 469.600 g/mol |
| XLogP3 | 4.300 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 6 |
| 可旋转键计数Rotatable Bond Count | 5 |
| 精确质量Exact Mass | 469.248 Da |
| 单同位素质量Monoisotopic Mass | 469.248 Da |
| 拓扑极表面积Topological Polar Surface Area | 81.600 Ų |
| 重原子数Heavy Atom Count | 35 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 770.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |